Phenotypes of susceptibility to amoxycillin (Amo), ticarcillin (Tic), cephalothin (Ctn) were determined in 1366 isolates of Enterobacteriaceae by disk method and beta-lactamases were identified in 243 strains belonging to different phenotypes of amoxycillin-resistant strains.
AmoR TicR Ctns strains (25%) were penicillinase producers and all of them were susceptible to the combination amoxicillin/clavulanic acid (Amo/CA) and ticarcillin/clavulanic acid (Tic/CA). AmoI/R Tics CtnR strains (12%) were cephalosporinase producers and resistance to Amo/CA was observed, except for Proteus vulgaris. AmoR TicR CtnR strains (18%) often produced two beta-lactamases (penicillinase and cephalosporinase) and they were resistant to Amo/CA; in this group, susceptibility to Tic/CA depends on the nature and the amount of the beta-lactamase produced, except for Serratia marcescens for which antibiotic resistance is probably due to other mechanisms. Tic/CA resistance was mainly found in Serratia marcescens (41%) and Enterobacter cloacae (36%).
Get full access to this article
View all access options for this article.
References
1.
BarryA LAyersL WGavanT LGerlachE HJonesR N (1984) In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers. European Journal of Clinical Microbiology3 (3) 203.
2.
CaseyPGlauserM (1983) Susceptibility of Gram-negative bacteria and Staphylococcus aureas to combinations of ticarcillin and clavulanic acid. European Journal of Clinical Microbiology2 (6), 541.
3.
ChabbertY AJaffeA (1982) Sch 29482: activity susceptible and B-lactam resistant variants of Enterobacteriaceae. Journal of Antimicrobial Chemotherapy9,(Suppl. C), 203.
4.
ChristensonJSquiresEDe LorenzoWCleelandR (1980) Relationship between B-lactamase activity of Serratia marcescens and resistance to B-lactam antibiotics. In: NelsonJ DGrassiC, Current Chemotherapy and Infectious Diseases, Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, Massachusetts, American Society for MicrobiologyEd. 1, 745.
5.
ClarkeA MZemcovS J V (1984) Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other B-lactams. Journal of Antimicrobial Chemotherapy13, 121.
6.
DeforgesLLe Van ThoiJSousseyC JDuvalJ (1985) Activité de l'association amoxicilline-acide clavulanique (augmentin) sur les souches d'isolement hospitalier. Pathologie Biologie33 (5), 301.
7.
FuchsP CBarryA LThornsberryCJonesR N (1984) In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates. Antimicrobial Agents and Chemotherapy25 (3), 392.
8.
Gonzalez-LamaZSoriaSLamaA MLopez-OrgeR H (1983) Isoelectric focusing of beta-lactamases from Klebsiella pneumoniae. In: 13th International Congress of Chemotherapy, Vienna, Part 89.
9.
GootzT DSandersC CGoeringR V (1982) Resistance to cefamandole; derepression of B-lactamases by cefoxitin and mutation in Enterobacter cloacae. Journal of Infectious Diseases146 (1), 34.
10.
GuionieM (1981) Bêta-lactamases et expression physiologique de la résistance des bacilles gram négatif aux Bêta-lactamines. Thèse de Doctorat d'Etat Es Sciences Physiques, Université Pierre et Marie Curie, Paris VI.
11.
GutmannLChabbertY A (1984) Different mechanisms of resistance to latamoxef (moxalactam) in Serratia marcescens. Journal of Antimicrobial Chemotherapy13, 15.
12.
HunterP AColemanKFisherJTaylorD (1980) In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin. Journal of Antimicrobial Chemotherapy6, 455.
13.
JarlierVBismuthRNicolasM HNiguyenJTruffotCGrossetJ (1984) Survey of the phenotypes of susceptibility to B-lactams in Enterobacteriaceae at the Pitié-Salpétrière Hospital. Journal of Antimicrobial Chemotherapy14, Suppl. B, 59.
14.
KingAGransdenW RPhillipsI (1983) The effect of clavulanic acid on the susceptibility to ticarcillin of Enterobacteriaceae and Pseudomonas aeruginosa that produce chromosomally and plasmid-determined B-lactamases. In: 13th International Congress of Chemotherapy, Vienna, Part 89.
15.
KontomichalouP (1983) Amoxycillin, carbenicillin and ticarcillin potentiation by clavulanic acid in Enterobacteriaceae and Pseudomonas aeruginosa and rapid methods for B-lactamase characterization and inhibition by clavulanic acid in intact bacteria. In: 13th International Congress of Chemotherapy, Vienna, Part 22.
16.
LabiaRBarthelemyMMassonJ M (1976) Multiplicité des bêta-lactamases: un problème d'isoenzymes. Compte Rendu de l'Académie des Sciences (Paris)283, D, 1597.
17.
LabiaRBarthelemyM (1979) L'enzymogramme des bêta-lactamases: adaptation en gel de la mêthode iodométrique. Annales de Microbiologic (Institut Pasteur)130B, 295.
18.
MatthewMHarrisA MMarshallM JRossG W (1975) The use of analytical isoelectric focusing for detection and identification of beta-lactamases. Journal of General Microbiology88, 169.
19.
MedeirosA AKentR LO'BrienT F (1974) Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. Antimicrobial agents and Chemotherapy6 (6), 791.
20.
NeuH CFuK P (1978) Clavulanic acid, a novel inhibitor of B-lactamases. Antimicrobial agents and Chemotherapy14 (5), 650.
21.
O'CallaghanC HMorrisAKirbyS MShinglerA H (1972) Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrobial agents and Chemotherapy1 (4), 283.
22.
PhilipponA MPaulG CNevotP A (1980) Synergy of clavulanic acid with penicillins against ampicillin and carbenicillin-resistant Gram-negative organisms, related to their type of beta-lactamase. In: Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy 1, 327.
23.
ReadingCColeM (1977) Clavulanic acid: a beta-lactamase inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrobial agents and Chemotherapy11, 852.
24.
RoyCFozASeguraCTiradoMFusterCReigR (1983) Plasmid-determined B-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy, 12, 507.
25.
SandersC CSandersW E (1979) Emergence of resistance to cefamandole: possible role of cefotoxin-inducible beta-lactamases. Antimicrobial agents and Chemotherapy15 (6), 792.
26.
SeebergA HTolxdorff-NeutzlingR MWiedemannB (1983) Chromosomal B-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins. Antimicrobial Agents and Chemotherapy23 (6) 918–925.
27.
SogaardP A (1979) Resistance types in Escherichia coli. 1. Occurrence and resistance to ampicillin, carbenicillin and cephalothin. Acta Pathlogica Microbiologica Scandinavica, Section B87, 235.
28.
SogaardP (1982) Resistance type in Enterobacteria cloacae. Occurrence and resistance to ampicillin, carbenicillin, cephalothin and mecillinam. Transfer of ampicillin resistance. Acta Pathologica Microbiologica Immunologica Scandinavica Section B90, 229.
29.
SykesR BMatthewM (1976) The B-lactamases of Gram-negative bacteria and their role in resistance to B-lactam antibiotics. Journal of Antimicrobial Chemotherapy2, 115.
30.
WernerVSandersC CSandersW EGoeringR V (1985) Role of B-lactamases and outer membrane proteins in multiple B-lactam resistance of Enterobacter cloacae. Antimicrobial Agents and Chemotherapy, 27 (4), 455.
31.
WiseRAndrewsJ MBedfordK A (1978) In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrobial Agents and Chemotherapy13 (3), 389.
